Kymera and Sanofi Advance IRAK4 Program With Selection of KT-485 for Clinical Development
CompanyDeals

Kymera and Sanofi Advance IRAK4 Program With Selection of KT-485 for Clinical Development

LG Chem's Cross-Linked Sodium Hyaluronate Gel Gains NMPA Approval for Midface Use
CompanyDrug

LG Chem’s Cross-Linked Sodium Hyaluronate Gel Gains NMPA Approval for Midface Use

Porton Pharma Partners With EVA Pharma to Boost CAR-T Cell Therapy in MENA
CompanyDeals

Porton Advanced Partners With EVA Pharma to Boost CAR-T Cell Therapy in MENA

Eli Lilly's Amyvid Sees FDA-Approved Label Update for Alzheimer's Diagnosis
CompanyDrug

Eli Lilly’s Amyvid Sees FDA-Approved Label Update for Alzheimer’s Diagnosis

Gilead Signs Licensing Pact With Kymera Therapeutics for CDK2-Targeted MGD
CompanyDeals

Gilead Signs Licensing Pact With Kymera Therapeutics for CDK2-Targeted MGD

SineuGene's ALS Gene Therapy SNUG01 Granted FDA Orphan Drug Designation
CompanyDrug

SineuGene’s ALS Gene Therapy SNUG01 Granted FDA Orphan Drug Designation

Acotec Scientific Wins NMPA Approval for Armoni-HP Balloon Catheter
CompanyDrug

Acotec Scientific Wins NMPA Approval for Armoni-HP Balloon Catheter

Immvira Bioscience Files for Hong Kong IPO to Advance Oncolytic Immunotherapy Pipeline
CompanyDeals

Immvira Bioscience Files for Hong Kong IPO to Advance Oncolytic Immunotherapy Pipeline

Genevector's JWK002 Gains NMPA IND Approval for XLRS Gene Therapy
CompanyDrug

Genevector’s JWK002 Gains NMPA IND Approval for XLRS Gene Therapy

CMS Plans Secondary Listing on Singapore Exchange to Enhance Shareholder Base and Liquidity
CompanyDeals

CMS Plans Secondary Listing on Singapore Exchange to Enhance Shareholder Base and Liquidity

Livzon's YJH-012 siRNA Drug Gets NMPA Green Light for Gout Trials
CompanyDrug

Livzon’s YJH-012 siRNA Drug Gets NMPA Green Light for Gout Trials

GE Healthcare Wins FDA Approval for Vizamyl Label Update in Alzheimer’s Detection
CompanyMedical Device

GE Healthcare Wins FDA Approval for Vizamyl Label Update in Alzheimer’s Detection